Dynamic Epidermal Cooling During Pulsed Dye Laser Treatment of Port Wine Stain Birthmark at High Fluences
NCT ID: NCT00540371
Last Updated: 2022-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
136 participants
OBSERVATIONAL
1999-12-31
2009-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The objective of this study is to document the degree of port wine stain lightening, the incidence of side effects and the presence of angiogenic factors induced during treatment with the pulsed dye laser in association with cooling agent. This information ultimately lead to improved treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Monitoring the Response of Port Wine Stain Birthmarks to Laser Therapy With Wide-field Functional Imaging Technologies
NCT01333553
Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths
NCT00573729
Combined Alexandrite and Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks
NCT00580944
Combined Bipolar Radiofrequency&Pulsed Dye Laser Treatment
NCT01775722
Effect of Pulsed Dye Laser on Photodynamic Therapy of Port-Wine Stains
NCT04536740
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The flashlamp-pumped pulsed dye laser has become the treatment of choice for port wine stain birthmarks; however, therapeutic challenges remain. The epidermis is not totally spared due to partial absorption of energy therein by melanin which presents an optical barrier through which the light must pass to reach the underlying blood vessels. Absorption of laser energy by melanin causes localized heating in the epidermis, which may, if not controlled, produce permanent complications such as hypertrophic scarring or dyspigmentation.
Clinical studies have demonstrated the efficacy and safety of cryogen spray cooling during pulsed laser treatment of port wine stain birthmarks. This technology allows the use of higher incident laser light dosages and has been demonstrated to improve treatment results. cryogen spray cooling also decreases treatment pain and the duration of post-laser treatment purpura.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Port wine stain Birthmark
Port wine stain Birthmark
Port wine stain Birthmark
Port wine stain Birthmark
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Port wine stain Birthmark
Port wine stain Birthmark
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Apparent good health as documented by medical history and physical examination
* Ability to understand and carry out subject instructions
Exclusion Criteria
* History of cutaneous photosensitivity
* History of photodermatoses, skin cancer or other cancer
* Any therapy to the proposed treatment sites within the previous two months
* Current participation in any other investigational drug evaluation
* Concurrent use of known photosensitizing drugs
* Inability to understand and carry out subject instructions
1 Month
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beckman Laser Institute University of California Irvine
OTHER
University of California, Irvine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beckman Laser Institute and Medical Center
Kristen Kelly, M.D.,Professor Departments of Dermatology and Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kristen Kelly, M.D
Role: PRINCIPAL_INVESTIGATOR
Beckman Laser Institue University of California Irvine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beckman Lase Institute Medical Clinic Unversity of California Irvine
Irvine, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19992154
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.